Author:
Krishnan Kailash,Campos Paula Bermell,Nguyen Thanh N.,Tan Chia Wei,Chan Siang Liang,Appleton Jason P.,Law ZheKang,Hollingworth Milo,Kirkman Matthew A.,England Timothy J.,Roffe Christine,Macleod Mary Joan,Dawson Jesse,Bayraktutan Ulvi,Werring David J.,Sprigg Nikola,Bath Philip M.
Abstract
Acute intracerebral hemorrhage is the most devastating stroke subtype and is associated with significant morbidity and mortality. Poor prognosis is associated with primary brain injury from the presenting hematoma, and despite advances in clinical trials of evacuation or reducing expansion, management is largely limited to supportive care and secondary prevention. Recent research has led to a better understanding of the pathophysiology of the cerebral edema surrounding the hematoma (perihematomal edema) and the identification of treatment targets and potential interventions. Some therapies have progressed to testing in phase 2 and 3 clinical trials, while novel agents are in development. This review focuses on the pathogenesis of perihematomal edema and its natural history and summarizes the results of potential interventions including preclinical and clinical studies. This review also lists the gaps in the current knowledge and suggests directions for future trials of perihematomal edema that could potentially change clinical practice.